First Japanese case of DNAJC12 deficiency diagnosed after 18 years of follow‐up for mild hyperphenylalaninemia
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70240
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (JP17ek0109276)
- Japan Agency for Medical Research and Development (JP20ek0109482)
- Japan Agency for Medical Research and Development (JP23ek0109636)
- Ministry of Health, Labour and Welfare (JPMH23FC1033)
This publication has 5 references indexed in Scilit:
- A Case of DNAJC12-Deficient Hyperphenylalaninemia Detected on Newborn Screening: Clinical Outcomes from Early DetectionInternational Journal of Neonatal Screening, 2024
- DNAJC12 in Monoamine Metabolism, Neurodevelopment, and NeurodegenerationMovement Disorders, 2023
- DNACJ12 deficiency in patients with unexplained hyperphenylalaninemia: two new patients and a novel variantMetabolic Brain Disease, 2021
- Heterogeneous clinical spectrum of DNAJC12-deficient hyperphenylalaninemia: from attention deficit to severe dystonia and intellectual disabilityJournal of Medical Genetics, 2017
- Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual DisabilityThe American Journal of Human Genetics, 2017